Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional Laser and Tirbanibulin for Keratinocyte Carcinomas
NCT07010692Phase 2Recruiting
- Start
- May 2025
- Primary completion
- May 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tirbanibulin in basal cell carcinoma (BCC), squamous cell carcinoma (SCC). Started May 2025; status: recruiting.
02
Drugs
tirbanibulin
03
Conditions
basal cell carcinoma (BCC)squamous cell carcinoma (SCC)
Beyond the preview
Go deeper on NCT07010692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07010692.